Eri Banno
Impact in
-
- Lung Cancer Treatments and Mutations
-
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Prostate Cancer Treatment and Research 4
-
- PI3K/AKT/mTOR signaling in cancer 6
- Gut microbiota and health 5
- Cancer therapeutics and mechanisms 3
- Co-authors
- Marco A. De Velasco (19 shared papers)Hirotsugu Uemura (22 shared papers)Kazutoshi Fujita (21 shared papers)Norio Nonomura (9 shared papers)Kazuto Nishio (21 shared papers)Koji Hatano (6 shared papers)Yosuke Togashi (13 shared papers)Kazuko Sakai (20 shared papers)
- Journals
- Cancer Research (6 papers)Annals of Oncology (5 papers)International Journal of Oncology (4 papers)Cancer Science (3 papers)The Prostate (2 papers)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Eri Banno
43 papers receiving 686 citations
Peers
Comparison fields: 5 of 88
- Pulmonary and Respiratory Medicine 229
- Oncology 188
- Urology 32
- Cancer Research 68
- Molecular Biology 296
Countries citing papers authored by Eri Banno
This map shows the geographic impact of Eri Banno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Banno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Banno more than expected).
Fields of papers citing papers by Eri Banno
This network shows the impact of papers produced by Eri Banno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Banno. The network helps show where Eri Banno may publish in the future.
Co-authors
The 25 scholars most cited alongside Eri Banno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 76 | |
| 2 | 2016 | 71 | |
| 3 | 2022 | 67 | |
| 4 | 2020 | 66 | |
| 5 | 2021 | 55 | |
| 6 | 2014 | 41 | |
| 7 | 2022 | 37 | |
| 8 | 2016 | 28 | |
| 9 | 2016 | 27 | |
| 10 | 2016 | 21 | |
| 11 | 2014 | 16 | |
| 12 | 2000 | 16 | |
| 13 | 2016 | 15 | |
| 14 | Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion. | 2015 | 15 |
| 15 | 2017 | 14 | |
| 16 | 2016 | 13 | |
| 17 | 2015 | 13 | |
| 18 | 2001 | 12 | |
| 19 | 2022 | 10 | |
| 20 | The Development of Child Language | 1992 | 9 |
About Eri Banno
Eri Banno is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Pathology and Forensic Medicine and Surgery, having authored 47 papers that have together received 692 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Gut microbiota and health (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Cancer Mechanisms and Therapy (5 papers), Prostate Cancer Treatment and Research (4 papers), Colorectal Cancer Screening and Detection (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (229 citations), Oncology (188 citations), Urology (32 citations), Cancer Research (68 citations) and Molecular Biology (296 citations). Eri Banno has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Marco A. De Velasco, Hirotsugu Uemura, Kazutoshi Fujita, Norio Nonomura, Kazuto Nishio, Koji Hatano, Yosuke Togashi, Kazuko Sakai, Yoshihiko Fujita and Makoto Matsushita. Their work appears in journals such as Cancer Research, Annals of Oncology, International Journal of Oncology, Cancer Science and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.